| Year |
Citation |
Score |
| 2022 |
Xiao W, Pahlavanneshan M, Eun CY, Zhang X, DeKalb C, Mahgoub B, Knaneh-Monem H, Shah S, Sohrabi A, Seidlits SK, Hill R. Matrix stiffness mediates pancreatic cancer chemoresistance through induction of exosome hypersecretion in a cancer associated fibroblasts-tumor organoid biomimetic model. Matrix Biology Plus. 14: 100111. PMID 35619988 DOI: 10.1016/j.mbplus.2022.100111 |
0.407 |
|
| 2020 |
Johnson BE, Hemrajani A, Ding X, Wesolowski M, Hill R, Zhang E, Dhanarajan AR. GRP78 expression and clinical outcomes in pancreatic cancer: A single institution review. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E16767 |
0.321 |
|
| 2020 |
Eun CY, DeKalb C, Xiao W, Zhang X, Hill R. Abstract 6414: Using 3D models to test the efficacy of targeting cancer-associated fibroblast exosomes to overcome chemoresistance in pancreatic cancer Cancer Research. 80: 6414-6414. DOI: 10.1158/1538-7445.Am2020-6414 |
0.482 |
|
| 2020 |
Xiao W, Eun C, Dekalb C, Zhang K, Hill R. Abstract 5108: Investigation of how extracellular matrix composition affects pancreatic cancer chemoresistance through the use of biomimetic models Tumor Biology. DOI: 10.1158/1538-7445.Am2020-5108 |
0.343 |
|
| 2017 |
Zeleniak AE, Huang W, Fishel ML, Hill R. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma. Neoplasia (New York, N.Y.). 20: 12-24. PMID 29175021 DOI: 10.1016/J.Neo.2017.10.004 |
0.476 |
|
| 2017 |
Gifford JB, Hill R. GRP78 Influences Chemoresistance and Prognosis in Cancer. Current Drug Targets. PMID 28641518 DOI: 10.2174/1389450118666170615100918 |
0.431 |
|
| 2017 |
Zeleniak AE, Huang W, Brinkman MK, Fishel ML, Hill R. Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget. PMID 28146435 DOI: 10.18632/Oncotarget.14869 |
0.521 |
|
| 2017 |
Dhanarajan AR, Hill R, Pappas SG, Abood GJ, Gnerlich JL, Ding X. Expression of GRP78 protein in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Journal of Clinical Oncology. 35: 323-323. DOI: 10.1200/Jco.2017.35.4_Suppl.323 |
0.36 |
|
| 2016 |
Richards KE, Zeleniak AE, Fishel ML, Wu J, Littlepage LE, Hill R. Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene. PMID 27669441 DOI: 10.1038/Onc.2016.353 |
0.49 |
|
| 2016 |
Gifford JB, Huang W, Zeleniak AE, Hindoyan A, Wu H, Donahue TR, Hill R. Expression Of GRP78, Master Regulator Of The Unfolded Protein Response, Increases Chemoresistance In Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. PMID 26939701 DOI: 10.1158/1535-7163.Mct-15-0774 |
0.393 |
|
| 2016 |
Huang W, Feist P, Hummon A, Hill R. Abstract A05: Proteomic analysis of exosome content changes induced by gemcitabine in pancreatic cancer stromal cells Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A05 |
0.509 |
|
| 2015 |
Falahat R, Wiranowska M, Gallant ND, Toomey R, Hill R, Alcantar N. A Cell ELISA for the quantification of MUC1 mucin (CD227) expressed by cancer cells of epithelial and neuroectodermal origin. Cellular Immunology. PMID 26435344 DOI: 10.1016/J.Cellimm.2015.09.009 |
0.3 |
|
| 2015 |
Taller D, Richards K, Slouka Z, Senapati S, Hill R, Go DB, Chang HC. On-chip surface acoustic wave lysis and ion-exchange nanomembrane detection of exosomal RNA for pancreatic cancer study and diagnosis. Lab On a Chip. 15: 1656-66. PMID 25690152 DOI: 10.1039/C5Lc00036J |
0.328 |
|
| 2013 |
Richards K, Gunn E, Hill R. Abstract 4038: Investigating the effect of glucose-regulated protein 78 (GRP78) inhibition in pancreatic cancer chemoresistance. Cancer Research. 73: 4038-4038. DOI: 10.1158/1538-7445.Am2013-4038 |
0.495 |
|
| 2012 |
Hill R, Li Y, Tran LM, Dry S, Calvopina JH, Garcia A, Kim C, Wang Y, Donahue TR, Herschman HR, Wu H. Cell intrinsic role of COX-2 in pancreatic cancer development. Molecular Cancer Therapeutics. 11: 2127-37. PMID 22784710 DOI: 10.1158/1535-7163.Mct-12-0342 |
0.434 |
|
| 2012 |
Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ, Li X, Dawson DW, Wu H. Integrative survival-based molecular profiling of human pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 1352-63. PMID 22261810 DOI: 10.1158/1078-0432.Ccr-11-1539 |
0.361 |
|
| 2010 |
Hill R, Calvopina JH, Kim C, Wang Y, Dawson DW, Donahue TR, Dry S, Wu H. PTEN loss accelerates KrasG12D-induced pancreatic cancer development. Cancer Research. 70: 7114-24. PMID 20807812 DOI: 10.1158/0008-5472.Can-10-1649 |
0.387 |
|
| 2009 |
Hill R, Wu H. PTEN, stem cells, and cancer stem cells. The Journal of Biological Chemistry. 284: 11755-9. PMID 19117948 DOI: 10.1074/Jbc.R800071200 |
0.344 |
|
| 2008 |
Lu X, Yang C, Hill R, Yin C, Hollander MC, Fornace AJ, Van Dyke T. Inactivation of gadd45a sensitizes epithelial cancer cells to ionizing radiation in vivo resulting in prolonged survival Cancer Research. 68: 3579-3583. PMID 18483238 DOI: 10.1158/0008-5472.Can-07-5533 |
0.638 |
|
| 2005 |
Simin K, Hill R, Song Y, Zhang Q, Bash R, Cardiff RD, Yin C, Xiao A, McCarthy K, van Dyke T. Deciphering cancer complexities in genetically engineered mice. Cold Spring Harbor Symposia On Quantitative Biology. 70: 283-90. PMID 16869764 DOI: 10.1101/Sqb.2005.70.038 |
0.497 |
|
| 2005 |
Hill R, Song Y, Cardiff RD, Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell. 123: 1001-11. PMID 16360031 DOI: 10.1016/J.Cell.2005.09.030 |
0.646 |
|
| 2005 |
Hill R, Song Y, Cardiff RD, Van Dyke T. Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. Cancer Research. 65: 10243-54. PMID 16288012 DOI: 10.1158/0008-5472.Can-05-1579 |
0.634 |
|
| Show low-probability matches. |